We describe a case of primary breast hemangiosarcoma with tonsillar metastasis that manifested as a profuse oropharyngeal hemorrhage. Th e patient was a 54-yearold woman who presented to the emergency department with oral bleeding. A thorough examination revealed a distorted morphology of the left tonsil and a hemorrhage originating from it. Conservative methods to control the hemorrhage failed, and tonsillectomy was carried out. Histopathologic analysis revealed that the left tonsil contained hemangiosarcoma cells of the same kind that had been removed from the breast. Primary hemangiosarcomas of the breast are rare; when they do occur, they usually recur locally and spread hematogenously. To the best of our knowledge, this is the fi rst case of a primary breast hemangiosarcoma with tonsillar metastasis to be reported in the literature. We present a detailed analysis of this case, and we review the relevant literature on metastatic tonsillar tumors, with attention to the role of therapeutic embolization.
Introduction
A sudden diff use hemorrhage from a tonsil poses a challenge in that the clinician must consider a long list of diff erential diagnoses, including infection, trauma, and malignancy. A fi nding of a distorted morphology of the tonsil, a tonsillar mass, leukoplakia, or an ulcerated lesion with raised borders should raise suspicion of a tumor. Tonsillectomy followed by histopathologic examination of the preparation brings diagnostic certainty. 1 Primary malignancies of the tonsils are not oft en encountered. When they do occur, the most common primary is squamous cell carcinoma; malignant lymphoma of the tonsil has also been reported. Squamous cell carcinoma of the palatine tonsil is oft en evident clinically as a visible oropharyngeal mass that is sometimes detected on routine examination. Patients may complain of odynophagia and sore throat. Other symptoms include unilateral otalgia, hemorrhage and, in advanced cases, trismus.
Tumor metastasis to a tonsil is extremely rare, accounting for only 0.8% of all tonsillar tumors. 2, 3 Metastasis to the tonsils has been reported with diff erent types of primary tumor, including cutaneous and mucosal melanomas, gastric and intestinal tract adenocarcinomas, hypernephroma, and various lung neoplasms. 1 Among the less common metastatic tonsillar tumors are mesothelioma, 4 hepatocellular carcinoma, 5 ovarian androblastoma, 6 seminoma, 7 anaplastic thyroid carcinoma, 8 pancreatic adenocarcinoma, 9 prostatic adenocarcinoma, 10 and gall bladder carcinoma. 11 Breast carcinoma is one of the rarest primary tumors to metastasize to the tonsil, as only 7 such cases have been reported in the literature. 1 Other breast malignancies, such as sarcoma, have not been implicated in tonsillar metastasis.
Tonsillar metastases rarely become apparent before the diagnosis of the primary neoplasm, and only a few cases of tonsillar metastasis as a presenting feature have been reported in the literature. 12 In most of these cases, the presenting symptoms were sore throat, an oral glo-bus sensation, and diff erent degrees of dysphagia and odynophagia. In other cases, patients were asymptomatic; their tonsillar neoplasm was detected incidentally during a routine oral examination. Hemorrhage as a presenting symptom has been very rarely reported. Tonsillar metastases can be bilateral or unilateral, depending on the nature of the primary neoplasm. In unilateral cases, the left tonsil is involved more oft en than the right. 1, 13, 14 Th e prognosis for patients with tonsillar metastasis is rather poor. Th e mean survival period aft er presentation of the metastatic disease is less than 9 months, regardless of the cell type of the primary malignancy. 1, 13, 14 We describe a rare case of a breast hemangiosarcoma metastatic to the tonsil that manifested as a profuse hemorrhage from the aff ected tonsil. To the best of our knowledge, this is the fi rst reported case of a primary breast hemangiosarcoma metastatic to the tonsil.
Case report
A 54-year-old woman presented to the emergency department at the Rambam Health Care Campus with a massive hemorrhage in her mouth. Two years earlier, she had undergone a lumpectomy to remove a high-grade hemangiosarcoma from her right breast. Th e tumor was removed with free margins, and no further therapy was administered. Fourteen months later, however, a mass was noticed in the breast scar tissue, and mammography revealed the presence of another mass behind the right nipple. Findings on fi ne-needle aspiration of both masses were suspicious for sarcoma. Th e patient underwent a right total mastectomy followed by chemotherapy (doxorubicin and ifosfamide) combined with radiotherapy. Seven months later, a local recurrence in the right chest wall necessitated a local wide excision, and two masses were removed.
Four weeks prior to the patient's presentation to our emergency department, she had undergone removal of a white plaque from her left tonsil, which had been suspected to represent a tonsillolith. Postoperatively, she began to experience brief episodes of recurring local hemorrhage that would cease spontaneously. However, when one hemorrhagic episode was profound and did not resolve spontaneously, she presented to the emergency department.
Upon admission, the patient's hemoglobin level was 7.6 g/dl. She was immediately treated with 3 units of packed red blood cells and crystalloid solutions for stabilization. Aft er fl uid resuscitation and blood replacement, she was examined by an otolaryngologist. Profuse hemorrhage was seen in the mouth and oropharynx emanating from a necrotic left tonsil. A marked asymmetry in the size of the tonsils was noted, with the left tonsil being twice the size of the right one. Aft er immediate conservative methods to control the hemorrhage failed, the patient was taken to the operating room. Aft er the administration of general anesthesia and endotracheal intubation, she underwent a bilateral tonsillectomy with meticulous hemostasis. She was then given an additional 3 units of packed red blood cells.
Th e patient's postoperative course was unremarkable. Th e removed tonsils were processed for pathologic and immunohistochemical studies. Th e right tonsil was found to be normal. Light microscopy of the left tonsil revealed pleomorphic, hyperchromatic endothelial cells in nodules of dilated anastomosing vascular channels (fi gure 1). Th e malignant tissue had infi ltrated the tonsillar soft tissue and was accompanied by areas of necrosis. Staining was A B uniformly positive for CD31 and variably positive for CD34, while HMG-45 and S-100 markers were both negative. Th ese features had been previously observed in the patient's breast hemangiosarcoma.
Positron-emission tomography/computed tomography (PET/CT) performed during hospitalization demonstrated increased uptakes that were suspected of indicating disseminated metastases in the chest wall, left submandibular lymph node, supraclavicular lymph node, right lobe of the liver, and left lateral aspect of the foramen magnum. PET/CT also demonstrated a 1-cm nodule in the middle lobe of the right lung and smaller nodules in the lower lobe. Th e patient remained hospitalized for 5 days postoperatively, and no hemorrhage from the tonsillar bed was noted.
Seven months following her tonsillectomy, the patient returned to the emergency department with a recent onset of hemorrhaging in her mouth. Physical examination revealed the presence of a 2-cm erythematous mass in the left tonsillar bed and a necrotic area within the mass that was surrounded with blood clots; the lesion bled intermittently. CT angiography detected a 19 × 11mm mass in the left tonsillar bed that had distorted the morphology of the oropharynx. Th e lesion was highly vascularized, and it demonstrated intense intralesional contrast enhancement; its blood supply was provided by branches of the left lingual artery (fi gure 2). Coil therapeutic embolization of the left lingual artery via the external carotid artery was performed, and the hemorrhage resolved immediately. Th e patient was released home without residual hemorrhage.
Discussion
Breast cancer accounts for approximately 25% of all malignant tumors in women. 1 In clinical practice, 46% of women with breast cancer have a regional or distant metastasis at the time of diagnosis, the most common sites being bone and the lung, liver, brain, and lymph nodes. 1 Hemangiosarcoma is a rare vascular tumor that accounts for 2% of all soft -tissue sarcomas, which together represent less than 1% of all cancers. 15, 16 It is a vasoformative malignancy that originates in endothelial cells and occurs most frequently in the skin and superfi cial soft tissues, although the deep tissues and the viscera have also been aff ected. 16, 17 Histologic fi ndings of an incomplete lining of the hemangiosarcomatous vessels support the tendency of these imperfect vessels to break down and bleed. 18 Hemangiosarcomas are aggressive tumors. Th ey occur most oft en in cutaneous areas of long-term sun exposure in the elderly, in patients with long-standing lymphedema, and in patients who have undergone radiation therapy or chemotherapy. Radical surgery is required, followed by radio-and/or chemotherapy. Despite treatment, the prognosis is poor. 15, 19 Hemangiosarcomas in the head and neck region are uncommon. In a study of 80 cases of hemangiosarcoma, Meis-Kindblom and Kindblom found that only 9 (11%) originated in the head and neck. 18 Fanburg-Smith et al reported that oral and salivary gland hemangiosarcomas were responsible for only 2% of all hemangiosarcomas. 17 Th ey also reported that primary hemangiosarcomas of the oral cavity most oft en involved the tongue and that secondary metastatic hemangiosarcomas most oft en involved the gingiva. Pawlik et al studied 29 cases of angiosarcoma of the scalp and found that the median actuarial survival was 28.4 months. 20 Primary cutaneous and deep nonoral hemangiosarcomas exhibit an extremely malignant behavior. Th ese lesions generally metastasize to the lung, bone, liver, brain, ovaries, and other skin and subcutaneous sites, resulting in death in 1 to 3 years. 16 Hemangiosarcomas metastatic to oral sites are exceedingly rare, accounting for only 0.1% of all malignant oral neoplasms. In the literature, only 10 cases of hemangiosarcoma metastatic to the oral cavity have been documented, including 8 cases in the gingiva Figure 2 . A: CT angiography shows the hypervascular lesion in the left palatine tonsil bed with necrotic areas within it. B: Another view shows the external carotid artery branches surrounding the enhanced mass. and 2 in the tongue. 17 Th ese metastatic tumors are oft en characterized as enlarging, painful masses of several weeks' duration, and they are occasionally associated with acute hemorrhage, anemia, or a coagulopathy. Th e prognosis of patients with hemangiosarcomas metastatic to oral locations is poor; death from disease, generally caused by respiratory compromise or massive bleeding, generally occurs in 1 to 15 months. 17 Th e lung is one of the most common sites of metastatic involvement. It commonly manifests as hemoptysis. In some cases, metastatic pleural infi ltration has resulted in hemopneumothorax. 16 Soft -tissue hemangiosarcomas, either primary or metastatic, present with various nonspecifi c symptoms and signs. Th eir multilocular nature results in a wide range of manifestations, including pain, swelling, extrusion, bowel obstruction, and hemorrhage. Fatal gastrointestinal metastases with severe bleeding have been reported in a few cases of liver and splenic hemangiosarcoma. 19, 21 Hemangiosarcomas can rupture spontaneously and cause severe internal bleeding that requires urgent treatment with catheter-directed embolization. Th is technique is useful in patients with acute arterial bleeding. Unfortunately, in such cases the spillage and seeding of the multiple hemangiosarcomatous lesions induces diff use hemorrhage with a subsequent loss of large amounts of blood. 19, 21 Hemangiosarcoma of the breast is rare, accounting for less than 0.1% of all malignant tumors of the breast. 2 Its overall incidence is estimated at between 0.002 and 0.005% per year. 2 It originates in the endothelial cells. It is generally aggressive, and it oft en takes a rapidly progressive clinical course. It invades the surrounding soft tissue and tends to recur locally. 3 Breast hemangiosarcomas frequently metastasize to distant sites, even aft er a long disease-free interval. Spread proceeds primarily through the bloodstream, and the metastasis can settle in the lungs, bones, liver, spleen, buccal mucosa, orbit, and skin. 3, 13, 14, [22] [23] [24] Involvement of the lymphatic structures is extremely unusual, and only a few cases of axillary lymph node metastasis of a breast hemangiosarcoma have been reported in the literature. 25, 26 Likewise, only a few cases of a breast tumor metastasizing to the tonsil have been reported. 1, 27, 28 In all of these cases, the primary tumors were carcinomas. Regardless of the location of the primary tumor, its histologic type, and the mode of treatment, patients with tonsillar metastases have a poor prognosis. A metastasis should be suspected in cases of an abrupt and unexplained tonsillar hemorrhage or a recurrent tonsillar hemorrhage in a patient with a known primary neoplasm. In such a case, a tonsillectomy should be performed to control the hemorrhage and to establish a proper histopathologic diagnosis. A recurrent hemorrhage from a tonsillar tumor or a tonsillar bed lesion, or following the resection of the tonsil, can be managed with angiographic therapeutic embolization. Th is technique involves superselective catheterization of the feeding arteries to the tumor bed followed by infusion of embolic particles to saturate the tumor bed, with the goal of inducing local necrosis and the subsequent halt of the hemorrhage. 23 Th erapeutic embolization may be considered in bleeding tumors that are categorized as vascular neoplasms, unresectable tumors, recurrent tumors, and metastatic tumors. Moreover, therapeutic embolization performed prior to the removal of a vascular lesion may reduce the risk of signifi cant surgical bleeding. Embolization of head and neck hypervascular tumors or uncontrollable hemorrhagic conditions is a well-established therapeutic procedure that can provide for the eff ective management of acute hemorrhage in patients with advanced head and neck cancer. 24, 25 
